Metagenomi Therapeutics (MGX) Earnings Date & Reports
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MGX is expected to report earnings to rise 47.27% to -81 cents per share on April 01
Q4'25
Est.
$-0.81
Q3'25
Beat
by $0.25
Q2'25
Beat
by $0.18
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.40
The last earnings report on November 11 showed earnings per share of -55 cents, beating the estimate of -80 cents. With 239.58K shares outstanding, the current market capitalization sits at 64.58M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MGX showed earnings on November 11, 2025. You can read more about the earnings report here.